Home
Epaper
Opinion
India
Video
My Kolkata
News
Places
People
Lifestyle
Happenings
Food
Puja
Try This
Edugraph
News
Career
Campus
18 Under 18
Colleges
Workshops
States
West Bengal
North East
Jharkhand
World
Business
Science & Tech
Health
Sports
Cricket
Football
Horse Racing
Entertainment
Culture
Bob Dylan@80
Heritage
Travel
Style
People
Books
Food
Arts
Music
Gallery
MY KOLKATA
EDUGRAPH
ADVERTISEMENT
Tuesday, 05 November 2024
Home
Opinion
India
Kolkata
World
Business
Sports
Cricket
Football
Horse Racing
My Kolkata
Places
People
Lifestyle
Happenings
Food
Try This
Entertainment
Edugraph
News
Career
Campus
18 Under 18
Colleges
Workshops
More
India
Kolkata
World
Business
Sports
My Kolkata
Entertainment
Edugraph
States
Life
GO
Home
Topic
Gilead Sciences
Gilead Sciences
Published 03.10.24, 06:09 AM
Deal on cheaper anti-HIV drug, lenacapavir, for low and lower-middle-income countries
By G.S. Mudur
Published 18.09.24, 05:21 AM
Health activists object to patent filed by US firm Gilead Sciences on anti-HIV drug
By G.S. Mudur
Published 23.07.23, 05:47 AM
Gilead's plan to delay new drug’s release to maximise profits, gaming the US patent system
By Rebecca Robbins, Sheryl Gay Stolberg
Published 12.04.21, 01:27 AM
Ban on export of remdesivir
By G.S. Mudur
Published 01.04.21, 02:25 AM
$8-million connect with city
By Sanjay Mandal
ADVERTISEMENT
Published 22.11.20, 02:26 AM
Covid-19: India set to stick with remdesivir
By G.S. Mudur
Published 07.06.20, 08:45 PM
AstraZeneca seeks merger with Gilead
By Reuters
Published 13.05.20, 11:03 PM
Candidate drug deal with India, Pak firms
By G.S. Mudur
Published 29.04.20, 08:49 PM
Chinese study damper on drug
By G.S. Mudur
Published 09.12.18, 11:03 PM
Pharma boss’s $8 million for Calcutta hospital
By Rith Basu
Published 28.06.19, 02:32 AM
Drug price promise ‘falter’
By Our Special Correspondent
ADVERTISEMENT